Z86.005 Billable Code FY2027 Status: Active

Z86.005: Pers hx of in-situ neoplasm of middle ear and resp sys

Personal history of in-situ neoplasm of middle ear and respiratory system

Effective Date: 2026-10-01
Dataset: ICD-10-CM FY2027
Source: Centers for Disease Control and Prevention (CDC)
Last Verified: 2026-10-01
✔

Quick Clinical & Billing Summary

What is ICD-10-CM code Z86.005? Z86.005 represents Pers hx of in-situ neoplasm of middle ear and resp sys. Under official CDC guidelines, this code is billable and specific for claim submission.

Current release: FY2027 (Effective October 1, 2026). Sourced directly from CDC NCHS files.

Code Hierarchy & Classification

⌊ Z86.005: Pers hx of in-situ neoplasm of middle ear and resp sys (Current Code)

Clinical Guidance & Documentation Standards

Clinical documentation should substantiate the medical necessity of this diagnosis, including laterality, anatomical site specificity, and clinical severity.

Associated Procedures & Medicare RVU Reimbursement

Open RVU Calculator →

Typical outpatient and office evaluation procedures frequently billed alongside diagnosis Z86.005:

CPT/HCPCS Description Work RVU Non-Facility Fee Facility Fee
99213 Office/outpatient visit, established patient, 20-29 minutes (Low MDM) 1.30 $91.69 $66.79
99214 Office/outpatient visit, established patient, 30-39 minutes (Moderate MDM) 1.92 $133.61 $100.21
96372 Therapeutic, prophylactic, or diagnostic injection (subcutaneous/intramuscular) 0.17 $18.34 $12.44
Based on official CMS 2026 Physician Fee Schedule conversion factor ($32.7476). Payments vary by locality GPCI.

CPT Modifier & Billing Rules

Modifier 25 Significant E/M

Append when a significant, separately identifiable evaluation and management service is provided on the same calendar day as a minor surgical procedure or injection.

Modifier 59 Distinct Service

Identifies procedures or services not normally reported together but distinct under the clinical circumstances. Use CMS X-modifiers (XE, XS, XP, XU) where required by Medicare.

Check NCCI Procedure to Procedure (PTP) unbundling rules in NCCI Checker →

Frequently Asked Questions about Z86.005

Is Z86.005 a billable ICD-10 code?

Yes, Z86.005 is a valid, billable and specific ICD-10-CM code. It can be reported as a primary or secondary diagnosis on medical claims.

What is the ICD-10 code for Pers hx of in-situ neoplasm of middle ear and resp sys?

The primary ICD-10-CM code for Pers hx of in-situ neoplasm of middle ear and resp sys is Z86.005.

What is the effective date of the current Z86.005 code?

The code is active for fiscal year FY2027, effective starting 2026-10-01.

AAPC CPC Exam Prep

Preparing for the Certified Professional Coder Exam?

Practice ICD-10-CM code identification, sequencing rules, and guideline application with the full CPC Exam Blueprint course.

Take Free Practice Exam →
Official Provenance: Sourced from CDC / NCHS FY2027 ICD-10-CM files. Report a Data Error
Verified: 2026-10-01